UPLIZNA(昕越)－Inebilizumab Injection

Trade Name: UPLIZNA(昕越)
Generic Name: Inebilizumab Injection
China Approval No.SJ20220007
MA holder: Horizon Therapeutics Ireland DAC(IRELAND)
Strength:100mg(10mL)/bottle*3 bottle/pack
Manufacturer: AstraZeneca Nijmegen B.V.(Netherlands)

 

Baiyue Pharma | Your Global Pharmaceutical Solutions Partner

Baiyue Pharma is a specialized global pharmaceutical solutions partner, dedicated to providing reliable supply and distribution of generic medicines, oncology products, and specialty drugs to wholesalers, pharmacies, hospitals, and CROs worldwide. Our operations are built on a foundation of quality, compliance, and patient safety.

• Our Expertise:
  Global Supply & Distribution: We provide GMP-certified bulk supply of finished dosage forms for major markets including the EU and USA, serving as your strategic partner for generic sourcing and wholesale distribution.
  Clinical Trial Support: We specialize in comparator drug sourcing for oncology clinical trials, ensuring supply assurance with fully documented cold chain logistics.
  Compliant Access Programs:We facilitate Named Patient Programs (NPP) and Compassionate Use pathways, enabling compliant access to unlicensed or hard-to-source therapeutics.
  Integrated Solutions: We offer end-to-end pharmaceutical solutions from sourcing to final delivery, including professional B2B sourcing and validated cold chain shipments.

We are committed to streamlining your supply chain and ensuring uninterrupted access to essential medicines through partnerships defined by reliability and expertise.

Global Pharmaceutical Supplier, Finished Dosage Form Supplier, Generic Medicines Wholesaler, Oncology Drugs Distributor, Clinical Trial Comparator Drug Sourcing, Named Patient Program Supplier, GMP Certified Medicine Supply, EU USA Pharmacy Market, End-to-End Pharmaceutical Solutions, Reliable Medicine Distributor.